Literature DB >> 19153992

Citrate transport and metabolism in mammalian cells: prostate epithelial cells and prostate cancer.

Maria E Mycielska1, Ameet Patel, Nahit Rizaner, Maciej P Mazurek, Hector Keun, Anup Patel, Vadivel Ganapathy, Mustafa B A Djamgoz.   

Abstract

Citrate, an organic trivalent anion, is a major substrate for generation of energy in most cells. It is produced in mitochondria and used either in the Krebs' cycle or released into cytoplasm through a specific mitochondrial carriers. Citrate can also be taken up from blood through different plasma membrane transporters. In the cytoplasm, citrate can be used ultimately for fatty acid synthesis, which is increased in cancer cells. Here, we review the ways in which citrate can be transported and discuss the changes in transport and metabolism that occur in cancer cells. The primary focus is on the prostate gland, which is known to produce and release large amounts of citrate during its normal secretory function. The significant changes that occur in citrate-related metabolism and transport in prostate cancer are the second focus. This review strives to relate these mechanisms to molecular biology on the one hand and to clinical applications on the other.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153992     DOI: 10.1002/bies.080137

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  46 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

2.  Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Authors:  Eleonora Napoli; Flora Tassone; Sarah Wong; Kathleen Angkustsiri; Tony J Simon; Gyu Song; Cecilia Giulivi
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

3.  Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.

Authors:  Chris Mühlhausen; Gajja S Salomons; Zoltan Lukacs; Eduard A Struys; Marjo S van der Knaap; Kurt Ullrich; René Santer
Journal:  J Inherit Metab Dis       Date:  2014-04-01       Impact factor: 4.982

4.  The Utility of [18F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography.

Authors:  Corinne Beinat; Tom Haywood; Yun-Sheng Chen; Chirag B Patel; Israt S Alam; Surya Murty; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

Review 5.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

Review 6.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

7.  Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage.

Authors:  Li Lai; Erin Reineke; Dale J Hamilton; John P Cooke
Journal:  Circulation       Date:  2019-01-02       Impact factor: 29.690

Review 8.  Flipping a citrate switch on liver cancer cells.

Authors:  Jeffrey M Peters
Journal:  J Biol Chem       Date:  2017-08-18       Impact factor: 5.157

Review 9.  Citrate chemistry and biology for biomaterials design.

Authors:  Chuying Ma; Ethan Gerhard; Di Lu; Jian Yang
Journal:  Biomaterials       Date:  2018-05-04       Impact factor: 12.479

10.  Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.

Authors:  Sarah-Maria Fendt; Eric L Bell; Mark A Keibler; Shawn M Davidson; Gregory J Wirth; Brian Fiske; Jared R Mayers; Matthias Schwab; Gary Bellinger; Alfredo Csibi; Akash Patnaik; Marie Jose Blouin; Lewis C Cantley; Leonard Guarente; John Blenis; Michael N Pollak; Aria F Olumi; Matthew G Vander Heiden; Gregory Stephanopoulos
Journal:  Cancer Res       Date:  2013-05-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.